Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Genevi??ve Lavoie
Affiliation
Institute for Research in Immunology and Cancer (IRIC)
ORCID
Career Start Year
2004
Papers
27
H Index
17
Expertise
CM4AI Collaborator
Sami Nourreddine (CM4AI)
PMID
Paper Title
Journal Title
Published Year
35167498
Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation.
JCI Insight
2022
36309522
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma.
Nat Commun
2022
35892282
Proteomic analysis of the actin cortex in interphase and mitosis.
J Cell Sci
2022
34125833
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.
PLoS Genet
2021
33710330
Correction: RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation.
Biochem J
2021
32433969
NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay.
Cell Rep
2020
31928973
F-Actin Interactome Reveals Vimentin as a Key Regulator of Actin Organization and Cell Mechanics in Mitosis.
Dev Cell
2020
31678930
Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.
Mol Cell Proteomics
2020
32572169
SPIN90 associates with mDia1 and the Arp2/3 complex to regulate cortical actin organization.
Nat Cell Biol
2020
32709883
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer.
Nat Commun
2020
31102422
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
Genes Chromosomes Cancer
2019
29440170
RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.
Cancer Res
2018
28096188
Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.
Mol Cell Biol
2017
27797342
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
J Clin Invest
2016
24532714
Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation.
Genes Dev
2014
25002506
Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3.
Proc Natl Acad Sci U S A
2014
22797077
RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.
Oncogene
2013
23967302
Expression of galectin-7 is induced in breast cancer cells by mutant p53.
PLoS One
2013
23401857
Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.
Mol Cell Biol
2013
23108403
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
Oncogene
2013
22827337
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation.
Biochem J
2012
21565170
Phosphorylation of human DNMT1: implication of cyclin-dependent kinases.
Biochem Biophys Res Commun
2011
21619587
PKC isoforms interact with and phosphorylate DNMT1.
BMC Biol
2011
23489154
Potential directions for drug development against galectin-7 in cancer.
Expert Opin Drug Discov
2009
17409449
Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Cancer Res
2007
16516860
The role of DNA hypomethylation in the control of stromelysin gene expression.
Biochem Biophys Res Commun
2006
15515126
Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status.
J Gene Med
2004
1 - 27 of 27
Column Actions
Search
Recommended Authors
Florent Dingli
Institut Curie, PSL Research University
Career Start Year
2011
Number of shared co-authors
0
Rebecca S Levin
Howard Hughes Medical Institute, University of California San Francisco
Career Start Year
2010
Number of shared co-authors
0
Eric Lau
Moffitt Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Yi-Hung Ou
The First Affiliated Hospital of Guangdong Pharmaceutical University
Career Start Year
2005
Number of shared co-authors
0
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2002
Number of shared co-authors
1
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
0
Hye Jin You
Research Institute, National Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
1
Michael A White
University of Georgia
Career Start Year
1994
Number of shared co-authors
0
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year
1993
Number of shared co-authors
0
Christoph Reinhard
Lilly Research Laboratories
Career Start Year
1992
Number of shared co-authors
0
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
0
Aykut Uren
Georgetown University Medical Center
Career Start Year
1991
Number of shared co-authors
0
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
0
Kun-Liang Guan
University of California San Diego
Career Start Year
1988
Number of shared co-authors
2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
1
Rosalie C Sears
Oregon Health and Science University
Career Start Year
1987
Number of shared co-authors
0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
2
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year
1985
Number of shared co-authors
1
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year
1984
Number of shared co-authors
2
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year
1976
Number of shared co-authors
5
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
0
Tony Hunter
Salk Institute for Biological Studies
Career Start Year
1968
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Philippe P Roux
IRIC - University of Montreal
Co-authored papers
20
Sami Nourreddine (CM4AI)
University of California San Diego
Co-authored papers
6
Antoine M??ant
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers
5
Joseph Tcherkezian
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers
5
L??o Aubert
IRIC - University of Montreal
Co-authored papers
4
Benoit Grondin
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers
3
Marc K Saba-El-Leil
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers
3
Thibault Houles
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers
3
Ewa K Paluch
University College London, University of Cambridge
Co-authored papers
3
Sylvain Meloche
Institute for Research in Immunology and Cancer
Co-authored papers
3
S??bastien Carreno
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers
2
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Co-authored papers
2
Andr?? Haman
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers
2
Trang Hoang
Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Co-authored papers
2
Steven P Gygi
Harvard Medical School
Co-authored papers
2
John Rush
Cell Signaling Technology Inc.
Co-authored papers
2
Murielle P Serres
Institut Pasteur, Universite de Paris, CNRS UMR3691
Co-authored papers
2
Edward L Huttlin
Harvard Medical School
Co-authored papers
2
Sichun Lin
Department of Pharmaceutical Sciences, University of Toronto
Co-authored papers
2
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Co-authored papers
2
Mathieu Tremblay
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers
1
Diogo F T Veiga
University of Campinas (UNICAMP)
Co-authored papers
1
Christoph J Fahrni
Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology
Co-authored papers
1
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Co-authored papers
1
Marie-Jos??e H??bert
Universite de Montreal
Co-authored papers
1
Justine S Paradis
Moores Cancer Center, University of California San Diego
Co-authored papers
1
Benoit Chabot
Agriculture and Agri-Food Canada
Co-authored papers
1
Khaled Ben El Kadhi
New York University
Co-authored papers
1
Beichen Gao
ETH Zurich
Co-authored papers
1
Milena Kosic
Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto
Co-authored papers
1
1 - 30